Transplant Medicine
Gene therapy protects livers from transplant-related injury
Published in Gene Therapy Weekly, March 25th, 2004
According to a study from the United States, "liver injury induced by ischemia/reperfusion (I/R) is the prime factor in delayed or loss graft function following transplantation. CD4+ T lymphocytes are key cellular mediators of antigen-independent inflammatory response triggered by I/R. We attempted to modulate rat liver I/R injury by targeted gene therapy with CD401g, which blocks the CD40-CD154 costimulation pathway."
"One hundred percent of Ad-CD401g-pretreated orthotopic liver transplants (OLTs) subjected to 24 hours of cold (4 degree C) ischemia survived >14 days (vs. 50%...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-03-25)
More Articles from Gene Therapy Weekly
- Gene Transfer
Retroviral constructs directed against CEA foster tumor cell transduction - Oncology
Apoptin expression kills human biliary tract cancer cells - Gene Delivery
Calfection gives scientists a way to transfect cells in suspension cultures - Genetic Engineering
DNA from modified plants are not transferred to the gastrointestinal tract - Neuroscience
Pseudotyped lentiviral vectors provide strong nervous system transduction - Angiology
Insulin-like growth factor I plasmids augment vessel growth where needed - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
